KVD900
KVD900-101
Phase 2 small_molecule completed
Quick answer
KVD900 for Hereditary Angioedema is a Phase 2 program (small_molecule) at KalVista Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- KalVista Pharmaceuticals
- Indication
- Hereditary Angioedema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed